VINESHA BYERS: Open Payments
NPI 1487177523 · EXCELSIOR SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,518 in 195 payments from 22 companies in 2025. Trend: 2023 $2,400 · 2024 $3,929 · 2025 $3,518
Food & beverage: $3,287Education: $232
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $855 |
| Janssen Biotech, Inc. | 18 | $424 |
| PFIZER INC. | 24 | $340 |
| UCB, Inc. | 13 | $228 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $228 |
| Novartis Pharmaceuticals Corporation | 10 | $181 |
| Kerecis Limited | 10 | $175 |
| Incyte Corporation | 11 | $160 |
| Amgen Inc. | 9 | $155 |
| E.R. Squibb & Sons, L.L.C. | 13 | $153 |
Products named: TREMFYA, RINVOQ, SKYRIZI, CIBINQO, DUPIXENT, Bimzelx, Kerecis SurgiClose, OPZELURA.
Industry payments across MO — which companies pay providers there.
